EpimAb Biotherapeutics
As of the edition of 20 October 2026, EpimAb Biotherapeutics runs 7 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 5 |
| Stopped | 1 |
| Status not established | 1 |
| Total | 7 |
Where its trials are
- Cancer: 7 trials led
- Lungs and airways: 2 trials led
- Blood and lymph: 1 trials led